###begin article-title 0
Angiotensin II induction of PDGF-C expression is mediated by AT1 receptor-dependent Egr-1 transactivation
###end article-title 0
###begin p 1
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
###end p 1
###begin p 2
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
Platelet-derived growth factors are a family of mitogens and chemoattractants comprising of four ligand genes (A-, B-, C-, D-chains) implicated in many physiologic and pathophysiologic processes, including atherosclerosis, fibrosis and tumorigenesis. Our understanding of the molecular mechanisms, which regulate PDGF-C transcription remains incomplete. Transient transfection analysis, conventional and quantitative real-time PCR revealed the induction of PDGF-C transcription and mRNA expression in smooth muscle cells (SMCs) exposed to the peptide hormone angiotensin (ATII), which induces Egr-1. Occupancy of a G + C-rich element in the proximal region of the PDGF-C promoter was unaffected by ATII. Instead we discovered, using both nuclear extracts and recombinant proteins with EMSA and ChIP analyses, the existence of a second Egr-1-binding element located 500 bp upstream. ATII induction of PDGF-C transcription is mediated by the angiotensin type 1 receptor (AT1R) and Egr-1 activation through this upstream element. DNAzyme ED5 targeting Egr-1 blocked ATII-inducible PDGF-C expression. Moreover, increased PDGF-C expression after exposure to ATII depends upon the differentiation state of the SMCs. This study demonstrates the existence of this novel ATII-AT1R-Egr-1-PDGF-C axis in SMCs of neonatal origin, but not in adult SMCs, where ATII induces Egr-1 but not PDGF-C.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 43 44 43 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 652 653 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 672 673 672 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8 B9 B10">8&#8211;10</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 760 765 760 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDGFC</italic>
###xml 1064 1065 1064 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1244 1245 1244 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1246 1247 1246 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1248 1249 1248 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 754 759 <span type="species:ncbi:9606">human</span>
###xml 1101 1106 <span type="species:ncbi:9606">human</span>
Platelet-derived growth factor-C (PDGF-C) (1), like PDGF-D are the two most recently identified members of the PDGF family of growth factors, which includes the well-characterized PDGF-A and PDGF-B. PDGFs are important regulators of cell proliferation and survival in many types of mesenchymal cells including smooth muscle cells (SMCs), connective tissue cells and fibroblasts. Studies over the last two decades have implicated PDGF-A and -B in pathophysiologic processes such as atherosclerosis, restenosis, fibrosis and tumorigenesis (2,3). Since its discovery in the same year as PDGF-D, PDGF-C has been found to participate in fibrotic disease (4,5), angiogenesis (6,7), embryogenesis (8-10), palate formation (11) and platelet activation (12). The human PDGFC gene is located on chromosome 4q32, which encodes a 345 amino acid protein with a two-domain structure: an N-terminal CUB-domain and a C-terminal growth factor domain (GFD). PDGF-CC is produced as a latent factor, requiring thereby activation by proteolysis to release the GFD from the CUB domain (1). PDGF-C mRNA is expressed in most human adult tissues, with highest levels in heart, kidney and pancreas and smaller amount are found in placenta, skeletal muscle and prostate (1,5,7).
###end p 5
###begin p 6
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 531 533 531 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1118 1120 1118 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1121 1123 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 806 809 <span type="species:ncbi:10116">rat</span>
###xml 835 838 <span type="species:ncbi:10116">rat</span>
###xml 959 962 <span type="species:ncbi:10116">rat</span>
Angiotensin II (ATII), the effector peptide of the renin-angiotensin system, is involved in blood pressure control, vascular tone and growth factor induction. Additionally, ATII is a pro-atherogenic factor as it is capable of stimulating vascular SMC proliferation through the generation of complex signaling events (13) that affect the expression of pathophysiologically relevant genes such as PDGF-A (14), PDGF-B (15) and PDGF-D (16). Vascular SMCs respond to ATII multiphasic manner: within seconds, ATII can activate PLC and Ca2+ mobilization; within minutes, protein kinase C (PKC) and phospholipase D (PLD) are activated; and within hours, NADH/NADPH oxidase activity is stimulated (17). The SMC response to ATII is influenced by its differentiation state (17). For example, in both cultured newborn rat arterial medial SMCs and rat arterial neointimal SMCs, PDGF-B mRNA expression is induced by ATII, but no change in B-chain expression is observed in rat adult SMCs (15). SMC heterogeneity is a well-known feature of this cell type (18). The 'contractile' state, which is typical of the differentiated artery (19,20), whereas the 'synthetic' state is characteristic of developing or pathologic arteries and the SMCs exhibit an epithelioid shape with enhanced proliferative and migratory activity.
###end p 6
###begin p 7
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 279 280 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 281 282 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
ATII has previously been shown to regulate PDGF-A (14), PDGF-B (15) and PDGF-D (16) transcription, however the ATII-inducible expression of each isoform may be mediated by distinct mechanisms. In the case of PDGF-D, ATII acts through reactive oxygen species (ROS), specifically H2O2 and Ets-1, whereas ATII-inducible PDGF-B expression, although not yet fully elucidated, has been shown to be dependent on Ras, ERK and c-Jun-terminal kinase (JNK) signaling. Furthermore, ATII activates the extracellular signal-related kinase (ERK) pathway to stimulate Egr-1 and PDGF-A expression via a G+C-rich region (located -76 to -47 bp) in the proximal PDGF-A promoter bearing Egr-1-binding elements (14,21). This element is strikingly similar to that in the proximal PDGF-C promoter (22). Egr-1 mediates inducible PDGF-A and PDGF-C transcription in cells exposed to FGF-2 through this proximal element (22,23). Since this element controls inducible PDGF-A expression in cells exposed to a variety of other agonists and conditions [such as ATII (14), PMA (21) and shear stress (24)], we hypothesized that this element in the PDGF-C promoter regulates altered expression in response to other stimulants. It is presently unknown whether ATII regulates the PDGF-C gene. This demonstration is important, as it would place ATII as an agonist governing the expression of every known PDGF ligand.
###end p 7
###begin p 8
###xml 245 247 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
This study reveals the existence of a second functional Egr-1-binding element in the PDGF-C promoter located approximately500 bp upstream of the proximal G + C-rich element previously shown by us to mediate FGF-2-inducible PDGF-C transcription (22). We report that ATII induction of PDGF-C transcription is mediated by the angiotensin type 1 receptor (AT1) and Egr-1 activation through this upstream element. Moreover, we demonstrate that ATII-inducible PDGF-C expression is SMC differentiation state-dependent and that the two Egr-1-binding elements operate independently.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Chemicals
###end title 10
###begin p 11
ATII (Sigma) was dissolved in water (Baxter), aliquoted and stored at -80degreesC. The ATII receptor inhibitor PD123319 was purchased from Sigma and Losartan was a generous gift from Merck, Sharp & Dohme (Sydney, Australia).
###end p 11
###begin title 12
Cell culture
###end title 12
###begin p 13
###xml 256 257 246 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 277 278 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 669 670 653 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 772 774 756 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 9 12 <span type="species:ncbi:10116">rat</span>
###xml 50 53 <span type="species:ncbi:10116">rat</span>
###xml 222 226 <span type="species:ncbi:9913">calf</span>
WKY12-22 rat neonatal (pup) aortic SMCs and adult rat aortic SMCs were cultured in Waymouth's MB752/1 medium (Life Technologies, Inc.), pH 7.4, supplemented with 10 U/ml penicillin, 10 microg/ml streptomycin and 10% fetal calf serum at 37degreesC and 5% CO2 in an Air Jacket CO2 incubator (model 60A0100a, Thermoline). At 90% confluence, the cells were rinsed twice with phosphate-buffered saline (PBS) solution and passaged by incubating with 0.05% trypsin and 0.02% ethylenediaminetetraacetic acid (EDTA) in Hank's balanced salt solution (BioWhittaker) for 1-3 min at 37degreesC and then tapping firmly. The cells were resuspended in growth medium and placed in 75 cm2 flasks. The SMCs were growth-arrested in serum-free media for 24 h prior to stimulation with ATII (10-7 M). In ATII receptor inhibitor studies, WKY12-22 cells were incubated with Losartan (1 microM) or PD123319 (1 microM) for 1 h and then treated with ATII for 2 h before mRNA extraction.
###end p 13
###begin title 14
Total RNA preparation and reverse transcriptase reaction
###end title 14
###begin p 15
Cells were washed twice with cold PBS and total RNA was extracted with TRIzol(R) (Life Technologies, Inc.). cDNA was synthesized from 5 microg of RNA using the Super Script III First Strand Synthesis Kit (Invitrogen, Carlsbad, USA) as per manufacturer's instructions. cDNA was stored at -20degreesC.
###end p 15
###begin title 16
Semi quantitative polymerase chain reaction (PCR)
###end title 16
###begin p 17
###xml 136 139 <span type="species:ncbi:10116">rat</span>
###xml 475 478 <span type="species:ncbi:10116">rat</span>
###xml 796 799 <span type="species:ncbi:10116">Rat</span>
PCR was performed utilizing the Platinum Tag polymerase kit. cDNA was amplified for PDGF-C, Egr-1 products. The set of primers used for rat PDGF-C was: forward, 5' -GGC ATG AGA GAG TTG TCA CTA TAT CTG GTA-3', and reverse, 5' -GTC CAA GTC TAT CTG CCA TCG ATC T-3' with denaturing temperature of 98degreesC for 1 min, followed by 22 cycles of 96degreesC for 30 s, 60degreesC for 30 s, 72degreesC for 30 s and extending at 72degreesC for 5 min, producing a 481 bp fragment. For rat Egr-1 amplification, primers used were: forward, 5'-GCC TTT TGC CTG TGA CAT TT-3', and reverse, 5'-AGC CCG GAG AGG AGT AAG AG-3', with amplification conditions of 98degreesC for 1 min; 94degreesC for 30 s, 60degreesC for 30 s, 72degreesC for 30 s repeated 30 times; 72degreesC for 1 min, producing a 230 bp amplicon. Rat beta-actin was used as a housekeeping gene. Primers used were, forward, 5'-AGC CAT GTA CGT AGC CAT CC-3', and reverse, 5'-CTC TCA GCT GTG GTG GTG AA-3'. The cycling conditions were 98degreesC for 1 min, followed by 20 cycles at 94degreesC for 30 s, 58degreesC for 30 s, 72degreesC for 30 s, finishing with 72degreesC for 2 min, amplifying a 228 bp product. PCR products were electrophoresed on 1.5% (w/v) agarose gel in 1 x TBA-EDTA at 90 V for 55 min in TBE buffer. Products were visualized by transillumination using the Gel Doc 2000 photographic system and Quantity One version 4.1.1 software.
###end p 17
###begin title 18
Quantitative real-time PCR
###end title 18
###begin p 19
###xml 1035 1036 1001 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1052 1053 1018 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 423 426 <span type="species:ncbi:10116">rat</span>
###xml 536 539 <span type="species:ncbi:10116">rat</span>
Real-time quantitative PCR was performed using ABI PRISM7700 Sequence Detection System in a final volume of 25 microl containing 1 microl of cDNA, 12.5 microl of SYBR Green Master Mix (Applied Biosystems), 0.5 microM of forward and reverse primers (Sigma) in DNAse-free water at the following PCR conditions: 50degreesC for 2 min, followed by 40 cycles of 95degreesC for 15 s and 60degreesC for 1 min. Primer sequences for rat GAPDH were (forward) 5'-ACA AGA TGG TGA AGG TCG GTG -3'; (reverse) 5'-AGA AGG CAG CCC TGG TAA CC-3'; and for rat PDGF-C (forward) 5'-CAG CAA GT GCA GCT CTC CA-3'; (reverse) 5'-GAC AAC TCT CTC ATG CCG GG -3'. Primer product size was verified on a 2% agarose/TBE gel. As an internal control and for normalization purposes, the level of mRNA expression for GAPDH, a housekeeping gene, was measured simultaneous to PDGF-C expression for each sample. The results are presented as relative amounts of PDGF-C mRNA versus the housekeeping mRNA value for the same sample. Statistical analysis was performed by paired t-test (*denotes P < 0.05) and compared with untreated controls.
###end p 19
###begin title 20
Western blot analysis
###end title 20
###begin p 21
###xml 212 215 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1184 1190 <span type="species:ncbi:9986">rabbit</span>
###xml 1197 1201 <span type="species:ncbi:9925">goat</span>
###xml 1211 1216 <span type="species:ncbi:10090">mouse</span>
###xml 1237 1248 <span type="species:ncbi:3704">horseradish</span>
WKY 12-22 SMCs were grown in 100 mm petri dishes, rendered growth quiescent by incubating in serum-free medium for 24 h and agonist was added for the times indicated or transfection was performed (pCB6-Egr-1 and CMV-Sp1). SMCs were washed twice with cold PBS and lyzed with RIPA buffer containing protease inhibitors (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 1% deoxycholate, 0.1% Triton X-100, 5 mg/ml leupeptin, 100 mM PMSF, 10% Trasylol, 0.5 M EDTA). The suspension was centrifuged for 10 min and the supernatant was collected. Protein estimation was carried out by BCA protein assay kit (Pierce, Rockford, IL, USA). Six microliters of 4 x SDS protein loading sample buffer along with 2 microl of 0.5 M DTT and 20 or 10 microg of lysates (dependent upon the experiment) were boiled for 5 min. Proteins were resolved in 10% SDS-PAGE and transferred onto Immobilon-P transfer membranes (Millipore). Membranes were blocked overnight with 5% skimmed milk in 1% PBS, 0.05% Tween-20 at 4degreesC. Membranes were then incubated with antibodies to Egr-1 (1:1000), Sp1 (1:1000) and beta-actin (1:30000) for 1 h at 22degreesC followed by incubation with their respective secondary antibody [anti-rabbit, anti-goat and anti-mouse IgG conjugated with horseradish peroxidase (HRP)] for 1 h. Membranes were incubated with chemiluminescence (Perkin Elmer Life Sciences, Shelton, CT) for 1 min and then exposed the film for 1-5 min.
###end p 21
###begin title 22
PDGF plasmid constructs
###end title 22
###begin p 23
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 567 570 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The 'Firefly' luciferase-based reporter construct pPDGF-C-797 was described previously (22). A mutant form of this construct (pPDGF-C-797.mutEgr-1) was prepared using Quick Change site-directed mutagenesis kit (Stratagene) with the following primers (forward: 5'- CGG GAG AGC CGC TGA GCA TAA AAA TAT CGC CAG GCG CGC GCT C-3' and reverse: 5'-GAG CGC GCG CCT GGC GAT ATT TTT ATG CTC AGC GGC TCT CCC G-3') targeting the -560 to -518 bp region of the PDGF-C promoter (relative to ATG site). The integrity of the reporter construct was confirmed by nucleotide sequencing. CMV-Sp1 and pCB6-Egr-1 were generous gifts of Robert Tjian and Vikas Sukhatme, respectively.
###end p 23
###begin title 24
Transient transfections
###end title 24
###begin p 25
###xml 1240 1242 1214 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 409 412 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 422 425 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 447 450 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 477 480 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
SMCs were seeded in 100 mm dishes and grown to 60% confluence and serum-arrested for 24 h before transfection with FuGENE6 (Roche Applied Science) at a ratio of 3 microl of FuGENE6 per microgram of DNA, with 5 microg of reporter construct pPDGF-C-797 and 0.5 microg of pRL-null, an internal control vector. In overexpression studies, SMCs were co-transfected with 1, 2 or 3 microg of either pCB6, pCB6-Egr-1, CMV-gutless, CMV-Sp1 or both pCB6 and CMV-gutless or pCB6-Egr-1 and CMV-Sp1. After incubation at 37degreesC for 24 h, luciferase activity was quantified using the Dual-Luciferase Reporter Assay (Promega). 'Firefly' luciferase activity was normalized to 'Renilla' data generated from pRL-null. When the effect of ED5 (0.4 microM), or its scrambled counterpart, ED5SCR was assessed, a 'double hit' transfection was used to maximize DNAzyme suppression of Egr-1 expression (first transfection 18 h prior to agonist stimulation of Egr-1, and the second, at the time of the stimulus). This pre-emptive delivery approach enables cellular uptake of the DNAzyme before Egr-1 is acutely induced by ATII. This routinely results in >75% uptake in our laboratory as determined by fluorescence microscopy with transfected FITC-labeled DNAzyme (25).
###end p 25
###begin title 26
Preparation of nuclear extracts and electrophoretic mobility shift assay (EMSA)
###end title 26
###begin p 27
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
Nuclear extracts were prepared and EMSA was performed as previously described (22).
###end p 27
###begin title 28
Statistical methods
###end title 28
###begin p 29
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data was analyzed for statistical significance using Student's t-test, and considered significant when P < 0.05. Error bars represent the mean +/- SE.
###end p 29
###begin title 30
Chromatin immunoprecipitation analysis (ChIP)
###end title 30
###begin p 31
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1292 1293 1260 1261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 32 37 <span type="species:ncbi:9606">human</span>
ChIP assays were performed with human SMCs at 80% confluency using a modification of a protocol previously described (26). Briefly, cross-linking was performed by the addition of 37% (w/v) formaldehyde for 15 min, followed by glycine incorporation to a final concentration 125 mM. The cells were washed with PBS, followed by 1 ml of immunoprecipitation (IP) buffer with protease inhibitors (26). Lysates were sonicated on ice for six rounds of 15 x 1 s pulses (output level 7) and then centrifuged at 14 000 r.p.m. for 10 min. Supernatants were fractioned evenly into tubes and incubated with anti-Sp1 and anti-Egr-1 antibodies (Santa Cruz Biotechnology, Inc.) for 30 min at 22degreesC, then at 4degreesC for 15 min, followed by centrifugation for 10 min at full speed. Prewashed Protein-A and -G beads were added and the slurry was rotated for 45 min at 4degreesC. The beads were washed five times with IP buffer without inhibitors prior the addition of 100 microl of 10% Chelex-100 and boiled for 10 min. Samples were digested with proteinase K (100 microg/ml) for 30 min at 55degreesC, then boiled for 10 min centrifuged and supernatant collected. DNA was purified by phenol-chloroform extraction and ethanol precipitation. DNA was dissolved in water and used for PCR reaction in 1 mM MgCl2, 0.1 mM dNTPs, 0.1 microM of primers and 1 U Platinum Taq Polymerase (Invitrogen). Cycling conditions were: 98degreesC for 1 min, 40 cycles of 98degreesC for 30 s, 58degreesC for 30 s and 72degreesC for 30 s followed by 72degreesC for 2 min. PDGF-C promoter containing the putative Egr-1-binding site was amplified (330 bp) with the following primers: forward 5'-TAG AGG TGT TCC GTG GAA GG-3' and reverse 5'-TTG TCC CCT CCC CTT CTC TA-3'.
###end p 31
###begin title 32
RESULTS AND DISCUSSION
###end title 32
###begin p 33
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 265 267 265 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 408 416 408 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 544 552 544 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 815 817 815 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 876 884 876 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 888 897 888 897 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1061 1063 1061 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1087 1088 1087 1088 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1114 1115 1114 1115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1334 1335 1334 1335 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1477 1479 1473 1475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1625 1626 1619 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 897 1654 897 1648 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="34">ATII induces PDGF-C expression and promoter activation in neonatal SMCs. Total RNA was isolated from neonatal (WKY12-22) SMCs cells treated with or without ATII (10<sup>&#8722;7</sup> M) for various times. (<bold>A</bold>) Conventional RT-PCR or (<bold>B</bold>) real-time PCR was performed for PDGF-C as described in the Materials and Methods section. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. (<bold>C</bold>) Transient transfection analysis was performed in WKY12-22 SMCs transfected with 5 &#181;g of pPDGF-C-797 and treated with or without ATII (10<sup>&#8722;7</sup> M) for 24 h. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05 compared to control.</p>
###xml 897 1654 897 1648 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="34">ATII induces PDGF-C expression and promoter activation in neonatal SMCs. Total RNA was isolated from neonatal (WKY12-22) SMCs cells treated with or without ATII (10<sup>&#8722;7</sup> M) for various times. (<bold>A</bold>) Conventional RT-PCR or (<bold>B</bold>) real-time PCR was performed for PDGF-C as described in the Materials and Methods section. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. (<bold>C</bold>) Transient transfection analysis was performed in WKY12-22 SMCs transfected with 5 &#181;g of pPDGF-C-797 and treated with or without ATII (10<sup>&#8722;7</sup> M) for 24 h. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05 compared to control.</p></caption>
###xml 1654 1654 1648 1648 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm923f1"/>
###xml 888 1654 888 1648 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="34">ATII induces PDGF-C expression and promoter activation in neonatal SMCs. Total RNA was isolated from neonatal (WKY12-22) SMCs cells treated with or without ATII (10<sup>&#8722;7</sup> M) for various times. (<bold>A</bold>) Conventional RT-PCR or (<bold>B</bold>) real-time PCR was performed for PDGF-C as described in the Materials and Methods section. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. (<bold>C</bold>) Transient transfection analysis was performed in WKY12-22 SMCs transfected with 5 &#181;g of pPDGF-C-797 and treated with or without ATII (10<sup>&#8722;7</sup> M) for 24 h. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05 compared to control.</p></caption><graphic xlink:href="gkm923f1"/></fig>
###xml 204 207 <span type="species:ncbi:10116">rat</span>
ATII has previously been shown to induce PDGF-A (14), PDGF-B (15) and PDGF-D (16) transcription in SMCs. To begin to investigate whether ATII can influence the expression of PDGF-C, we isolated mRNA from rat neonatal aortic SMCs (WKY12-22 cells) exposed to ATII (10-7 M) for various times. Conventional RT-PCR revealed that PDGF-C was basally expressed and was transiently induced by ATII, maximally at 2 h (Figure 1A). Quantitative real-time PCR demonstrated a 2-fold increase in PDGF-C mRNA levels at 1 h and maximal 3-fold induction by 2 h (Figure 1B). To establish that PDGF-C is under the transcriptional control of ATII, transient transfection was performed in WKY12-22 SMCs with pPDGF-C-797, a 'Firefly' luciferase-based reporter construct bearing 797 bp of the PDGF-C promoter, prior to exposure to ATII (10-7 M). Treatment with ATII induced PDGF-C promoter activity (Figure 1C). Figure 1.ATII induces PDGF-C expression and promoter activation in neonatal SMCs. Total RNA was isolated from neonatal (WKY12-22) SMCs cells treated with or without ATII (10-7 M) for various times. (A) Conventional RT-PCR or (B) real-time PCR was performed for PDGF-C as described in the Materials and Methods section. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. (C) Transient transfection analysis was performed in WKY12-22 SMCs transfected with 5 microg of pPDGF-C-797 and treated with or without ATII (10-7 M) for 24 h. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05 compared to control.
###end p 33
###begin p 34
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 190 191 190 191 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 217 218 217 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 437 438 437 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 580 582 576 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 728 729 722 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
ATII induces PDGF-C expression and promoter activation in neonatal SMCs. Total RNA was isolated from neonatal (WKY12-22) SMCs cells treated with or without ATII (10-7 M) for various times. (A) Conventional RT-PCR or (B) real-time PCR was performed for PDGF-C as described in the Materials and Methods section. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. (C) Transient transfection analysis was performed in WKY12-22 SMCs transfected with 5 microg of pPDGF-C-797 and treated with or without ATII (10-7 M) for 24 h. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05 compared to control.
###end p 34
###begin p 35
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 380 382 380 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 400 402 400 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 451 453 451 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 462 470 462 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;35/&#8722;1)</sup>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 607 615 607 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 712 720 712 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 883 891 883 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1036 1038 1036 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1047 1055 1047 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;35/&#8722;1)</sup>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1178 1180 1178 1180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1189 1197 1189 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;35/&#8722;1)</sup>
###xml 1267 1275 1267 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1437 1446 1437 1446 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 1542 1543 1542 1543 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1638 1640 1638 1640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1656 1658 1656 1658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1667 1675 1667 1675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;35/&#8722;1)</sup>
###xml 1876 1877 1876 1877 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1969 1971 1969 1971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 2001 2002 2001 2002 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2103 2104 2103 2104 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2117 2119 2117 2119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2128 2136 2128 2136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;35/&#8722;1)</sup>
###xml 1446 2340 1446 2336 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="36">ATII does not induce binding to the Egr-1/Sp1-binding site (&#8722;35/&#8722;1 bp) in the PDGF-C promoter. (<bold>A</bold>) EMSA was performed using nuclear extracts from WKY12-22 SMCs treated with or without ATII (10<sup>&#8722;7</sup> M) for 1 h and <sup>32</sup>P-Oligo C<sup>(&#8722;35/&#8722;1)</sup>. Supershift analysis using antibodies targeting Sp1 demonstrate that nucleoprotein complex Na contains Sp1. Antibodies directed towards Egr-1 reveal that none of the complexes contain Egr-1 protein. (<bold>B</bold>) RT-PCR demonstrates that Egr-1 is inducibly expressed in WKY12-22 SMCs exposed to ATII (10<sup>&#8722;7</sup> M) for the indicated times. (<bold>C</bold>) Western blot analysis demonstrates that ATII increases Egr-1 protein expression in WKY12-22 SMCs. (<bold>D</bold>) EMSA using <sup>32</sup>P-Oligo C<sup>(&#8722;35/&#8722;1)</sup> and nuclear extracts from WKY12-22 SMCs treated with FGF-2 (25 &#181;g/ml) for 1 h. Nucleoprotein complexes N1 and N2 contain Sp1, and N3 contains Egr-1 as demonstrated by antibody-based band elimination.</p>
###xml 1446 2340 1446 2336 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="36">ATII does not induce binding to the Egr-1/Sp1-binding site (&#8722;35/&#8722;1 bp) in the PDGF-C promoter. (<bold>A</bold>) EMSA was performed using nuclear extracts from WKY12-22 SMCs treated with or without ATII (10<sup>&#8722;7</sup> M) for 1 h and <sup>32</sup>P-Oligo C<sup>(&#8722;35/&#8722;1)</sup>. Supershift analysis using antibodies targeting Sp1 demonstrate that nucleoprotein complex Na contains Sp1. Antibodies directed towards Egr-1 reveal that none of the complexes contain Egr-1 protein. (<bold>B</bold>) RT-PCR demonstrates that Egr-1 is inducibly expressed in WKY12-22 SMCs exposed to ATII (10<sup>&#8722;7</sup> M) for the indicated times. (<bold>C</bold>) Western blot analysis demonstrates that ATII increases Egr-1 protein expression in WKY12-22 SMCs. (<bold>D</bold>) EMSA using <sup>32</sup>P-Oligo C<sup>(&#8722;35/&#8722;1)</sup> and nuclear extracts from WKY12-22 SMCs treated with FGF-2 (25 &#181;g/ml) for 1 h. Nucleoprotein complexes N1 and N2 contain Sp1, and N3 contains Egr-1 as demonstrated by antibody-based band elimination.</p></caption>
###xml 2340 2340 2336 2336 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm923f2"/>
###xml 1437 2340 1437 2336 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="36">ATII does not induce binding to the Egr-1/Sp1-binding site (&#8722;35/&#8722;1 bp) in the PDGF-C promoter. (<bold>A</bold>) EMSA was performed using nuclear extracts from WKY12-22 SMCs treated with or without ATII (10<sup>&#8722;7</sup> M) for 1 h and <sup>32</sup>P-Oligo C<sup>(&#8722;35/&#8722;1)</sup>. Supershift analysis using antibodies targeting Sp1 demonstrate that nucleoprotein complex Na contains Sp1. Antibodies directed towards Egr-1 reveal that none of the complexes contain Egr-1 protein. (<bold>B</bold>) RT-PCR demonstrates that Egr-1 is inducibly expressed in WKY12-22 SMCs exposed to ATII (10<sup>&#8722;7</sup> M) for the indicated times. (<bold>C</bold>) Western blot analysis demonstrates that ATII increases Egr-1 protein expression in WKY12-22 SMCs. (<bold>D</bold>) EMSA using <sup>32</sup>P-Oligo C<sup>(&#8722;35/&#8722;1)</sup> and nuclear extracts from WKY12-22 SMCs treated with FGF-2 (25 &#181;g/ml) for 1 h. Nucleoprotein complexes N1 and N2 contain Sp1, and N3 contains Egr-1 as demonstrated by antibody-based band elimination.</p></caption><graphic xlink:href="gkm923f2"/></fig>
###xml 1114 1117 <span type="species:ncbi:10116">rat</span>
ATII induction of PDGF-A expression is mediated via ERK-dependent Egr-1 binding to a G + C-rich region of the PDGF-A promoter at overlapping Egr-1/Sp1-binding sites (-76 to -47 bp) (14). To determine whether ATII induces Egr-1 binding to a similar region in the proximal PDGF-C promoter, we performed EMSA using nuclear extracts from WKY12-22 SMCs treated with or without ATII (10-7 M) for 1 h and a 32P-labeled double-stranded oligonucleotide probe [32P-Oligo C(-35/-1)] previously shown to bind FGF-2-inducible Egr-1 (22). Four nucleoprotein complexes formed, three major (Na, Nc, Nd) and one minor (Nb) (Figure 2A). Supershift analysis using antibodies targeting Sp1 revealed protein complex Na contains Sp1 (Figure 2A). However, to our surprise, antibodies to Egr-1 (or ATF4) did not alter the binding profile, despite the induction of Egr-1 mRNA and protein expression by ATII (Figure 2B and C). As a control for the antibody, we performed EMSA using nuclear extracts from WKY12-22 SMCs treated with FGF-2 (25 ng/ml) together with 32P-Oligo C(-35/-1). As previously obtained using extracts from FGF-2-treated rat SMCs (22), six nucleoprotein complexes (N1-N6) formed using 32P-Oligo C(-35/-1), including one complex containing supershiftable Egr-1 protein (N3) (Figure 2D). These results indicate that although ATII induces Egr-1 in WKY12-22 SMCs, Egr-1 does not interact with the proximal G + C-rich region of the PDGF-C promoter. Figure 2.ATII does not induce binding to the Egr-1/Sp1-binding site (-35/-1 bp) in the PDGF-C promoter. (A) EMSA was performed using nuclear extracts from WKY12-22 SMCs treated with or without ATII (10-7 M) for 1 h and 32P-Oligo C(-35/-1). Supershift analysis using antibodies targeting Sp1 demonstrate that nucleoprotein complex Na contains Sp1. Antibodies directed towards Egr-1 reveal that none of the complexes contain Egr-1 protein. (B) RT-PCR demonstrates that Egr-1 is inducibly expressed in WKY12-22 SMCs exposed to ATII (10-7 M) for the indicated times. (C) Western blot analysis demonstrates that ATII increases Egr-1 protein expression in WKY12-22 SMCs. (D) EMSA using 32P-Oligo C(-35/-1) and nuclear extracts from WKY12-22 SMCs treated with FGF-2 (25 microg/ml) for 1 h. Nucleoprotein complexes N1 and N2 contain Sp1, and N3 contains Egr-1 as demonstrated by antibody-based band elimination.
###end p 35
###begin p 36
###xml 96 97 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 192 194 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 210 212 210 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 221 229 221 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;35/&#8722;1)</sup>
###xml 430 431 430 431 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 523 525 523 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 555 556 555 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 657 658 657 658 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 671 673 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 682 690 682 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;35/&#8722;1)</sup>
ATII does not induce binding to the Egr-1/Sp1-binding site (-35/-1 bp) in the PDGF-C promoter. (A) EMSA was performed using nuclear extracts from WKY12-22 SMCs treated with or without ATII (10-7 M) for 1 h and 32P-Oligo C(-35/-1). Supershift analysis using antibodies targeting Sp1 demonstrate that nucleoprotein complex Na contains Sp1. Antibodies directed towards Egr-1 reveal that none of the complexes contain Egr-1 protein. (B) RT-PCR demonstrates that Egr-1 is inducibly expressed in WKY12-22 SMCs exposed to ATII (10-7 M) for the indicated times. (C) Western blot analysis demonstrates that ATII increases Egr-1 protein expression in WKY12-22 SMCs. (D) EMSA using 32P-Oligo C(-35/-1) and nuclear extracts from WKY12-22 SMCs treated with FGF-2 (25 microg/ml) for 1 h. Nucleoprotein complexes N1 and N2 contain Sp1, and N3 contains Egr-1 as demonstrated by antibody-based band elimination.
###end p 36
###begin p 37
###xml 148 156 148 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 257 265 257 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 457 459 457 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 478 480 478 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 513 515 513 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 523 534 523 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 568 576 568 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 700 702 700 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 710 721 710 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 723 731 723 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 745 753 745 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 802 810 802 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 824 832 824 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 922 930 922 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 944 952 944 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1165 1173 1165 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1194 1202 1194 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1280 1282 1280 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1385 1393 1385 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1407 1415 1407 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1665 1673 1665 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1754 1762 1754 1762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1889 1898 1889 1898 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 2140 2142 2140 2142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 2245 2256 2245 2256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 1898 2517 1898 2517 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="38">Proximal region of the PDGF-C promoter. A consensus Egr-1-binding element was found &#8722;543 to &#8722;535 bp in the PDGF-C promoter upstream from the G + C-rich element (located &#8722;35 to &#8722;1 bp) previously found to contain an overlapping Egr-1/Sp1 site (<xref ref-type="bibr" rid="B22">22</xref>). The Egr-1 consensus element is denoted by bold type and underline (contained with EMSA probe, PDGF-C<sup>(&#8722;560/&#8722;518)</sup> denoted by italics), and the G + C-rich element is defined by bold type and underline. The relative base pairs are represented by numbers in bold type and the curved arrow represents the putative transcriptional start site (as defined by UCSC Genome Database).</p>
###xml 1898 2517 1898 2517 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="38">Proximal region of the PDGF-C promoter. A consensus Egr-1-binding element was found &#8722;543 to &#8722;535 bp in the PDGF-C promoter upstream from the G + C-rich element (located &#8722;35 to &#8722;1 bp) previously found to contain an overlapping Egr-1/Sp1 site (<xref ref-type="bibr" rid="B22">22</xref>). The Egr-1 consensus element is denoted by bold type and underline (contained with EMSA probe, PDGF-C<sup>(&#8722;560/&#8722;518)</sup> denoted by italics), and the G + C-rich element is defined by bold type and underline. The relative base pairs are represented by numbers in bold type and the curved arrow represents the putative transcriptional start site (as defined by UCSC Genome Database).</p></caption>
###xml 2517 2517 2517 2517 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm923f3"/>
###xml 1889 2517 1889 2517 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="38">Proximal region of the PDGF-C promoter. A consensus Egr-1-binding element was found &#8722;543 to &#8722;535 bp in the PDGF-C promoter upstream from the G + C-rich element (located &#8722;35 to &#8722;1 bp) previously found to contain an overlapping Egr-1/Sp1 site (<xref ref-type="bibr" rid="B22">22</xref>). The Egr-1 consensus element is denoted by bold type and underline (contained with EMSA probe, PDGF-C<sup>(&#8722;560/&#8722;518)</sup> denoted by italics), and the G + C-rich element is defined by bold type and underline. The relative base pairs are represented by numbers in bold type and the curved arrow represents the putative transcriptional start site (as defined by UCSC Genome Database).</p></caption><graphic xlink:href="gkm923f3"/></fig>
###xml 2517 2526 2517 2526 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 2578 2579 2578 2579 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2674 2676 2674 2676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 2692 2694 2692 2694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2702 2713 2702 2713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 2717 2719 2717 2719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2734 2745 2734 2745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 2815 2817 2815 2817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2825 2836 2825 2836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 3192 3194 3192 3194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 3209 3220 3209 3220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 3322 3323 3322 3323 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 3363 3365 3363 3365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 3490 3491 3490 3491 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 3684 3685 3684 3685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2526 3710 2526 3710 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="39">ATII induces Egr-1 binding to the PDGF-C promoter. (<bold>A</bold>) EMSA was performed using nuclear extracts from neonatal SMCs treated with or without ATII (10<sup>&#8722;7</sup> M) for 1 h and <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> or <sup>32</sup>P-mEgr-1-PDGF-C<sup>(&#8722;560/&#8722;518)</sup>. Two nucleoprotein complexes (Ni and Nii) formed after incubation of <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> with nuclear extracts from cells untreated or treated with ATII. Supershift/band elimination analysis using antibodies to Sp1 and Egr-1 reveal complex Ni contains Sp1 and Egr-1, and complex Nii to contain only Egr-1. Antibodies to ATF4 did not promote shift in any complex. In reactions containing nuclear extracts from untreated or ATII-treated SMCs and <sup>32</sup>P-mEgr-1-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> (mutant form of the oligonucleotide in which consensus Egr-1 site mutated), neither complex formed. (<bold>B</bold>) Assessment of band intensities in the <sup>32</sup>P-PDGF-C/ATII groups by scanning densitometry. Complex densities for Ni and Nii are indicated. NT denotes non-ATII-treated. (<bold>C</bold>) ChIP studies show that under basal conditions Sp1 is bound to the authentic PDGF-C promoter, and that both Egr-1 and Sp1 are bound to the promoter upon exposure to ATII. Asterisk (*) denotes <italic>P</italic> &lt; 0.01 relative to ATII.</p>
###xml 2526 3710 2526 3710 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="39">ATII induces Egr-1 binding to the PDGF-C promoter. (<bold>A</bold>) EMSA was performed using nuclear extracts from neonatal SMCs treated with or without ATII (10<sup>&#8722;7</sup> M) for 1 h and <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> or <sup>32</sup>P-mEgr-1-PDGF-C<sup>(&#8722;560/&#8722;518)</sup>. Two nucleoprotein complexes (Ni and Nii) formed after incubation of <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> with nuclear extracts from cells untreated or treated with ATII. Supershift/band elimination analysis using antibodies to Sp1 and Egr-1 reveal complex Ni contains Sp1 and Egr-1, and complex Nii to contain only Egr-1. Antibodies to ATF4 did not promote shift in any complex. In reactions containing nuclear extracts from untreated or ATII-treated SMCs and <sup>32</sup>P-mEgr-1-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> (mutant form of the oligonucleotide in which consensus Egr-1 site mutated), neither complex formed. (<bold>B</bold>) Assessment of band intensities in the <sup>32</sup>P-PDGF-C/ATII groups by scanning densitometry. Complex densities for Ni and Nii are indicated. NT denotes non-ATII-treated. (<bold>C</bold>) ChIP studies show that under basal conditions Sp1 is bound to the authentic PDGF-C promoter, and that both Egr-1 and Sp1 are bound to the promoter upon exposure to ATII. Asterisk (*) denotes <italic>P</italic> &lt; 0.01 relative to ATII.</p></caption>
###xml 3710 3710 3710 3710 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm923f4"/>
###xml 2517 3710 2517 3710 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="39">ATII induces Egr-1 binding to the PDGF-C promoter. (<bold>A</bold>) EMSA was performed using nuclear extracts from neonatal SMCs treated with or without ATII (10<sup>&#8722;7</sup> M) for 1 h and <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> or <sup>32</sup>P-mEgr-1-PDGF-C<sup>(&#8722;560/&#8722;518)</sup>. Two nucleoprotein complexes (Ni and Nii) formed after incubation of <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> with nuclear extracts from cells untreated or treated with ATII. Supershift/band elimination analysis using antibodies to Sp1 and Egr-1 reveal complex Ni contains Sp1 and Egr-1, and complex Nii to contain only Egr-1. Antibodies to ATF4 did not promote shift in any complex. In reactions containing nuclear extracts from untreated or ATII-treated SMCs and <sup>32</sup>P-mEgr-1-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> (mutant form of the oligonucleotide in which consensus Egr-1 site mutated), neither complex formed. (<bold>B</bold>) Assessment of band intensities in the <sup>32</sup>P-PDGF-C/ATII groups by scanning densitometry. Complex densities for Ni and Nii are indicated. NT denotes non-ATII-treated. (<bold>C</bold>) ChIP studies show that under basal conditions Sp1 is bound to the authentic PDGF-C promoter, and that both Egr-1 and Sp1 are bound to the promoter upon exposure to ATII. Asterisk (*) denotes <italic>P</italic> &lt; 0.01 relative to ATII.</p></caption><graphic xlink:href="gkm923f4"/></fig>
After further examination of the PDGF-C promoter, we identified a second Egr-1-binding element (5'-CGCCCC CGC-3') upstream (at position -543/-535) (Figure 3). This putative binding motif resides within the PDGF-C luciferase-based reporter construct used in Figure 1C, which was activated by ATII. To establish whether ATII induces binding to this putative element, we performed EMSA using nuclear extracts from WKY12-22 SMCs treated with or without ATII (10-7 M) for 1 h, and a 32P-labeled oligonucleotide probe [32P-PDGF-C(-560/-518)] whose sequence spans -543/-535 (Figure 4A). Two complexes, one more intense (Ni) than the other (Nii), formed when extracts from untreated SMCs were incubated with 32P-PDGF-C(-560/-518) (Figure 4A, lane 2 and Figure 4B). Complex Nii was induced upon ATII treatment (Figure 4A, lane 3 and Figure 4B), and antibody-based complex elimination analysis revealed it to contain Egr-1 protein (Figure 4A, lane 5 and Figure 4B). Complex Ni, whose intensity was also increased by ATII, contains both Sp1 and Egr-1, with Sp1 the predominant occupant. Sp1 antibodies supershifted the complex, whereas Egr-1 antibodies reduced its intensity (Figure 4A, lanes 4 and 5 and Figure 4B). In support of these data, Sp1 and Egr-1 are known to physically interact (27). In contrast, antibodies to ATF4 had no significant effect on the binding profile of either complex (Figure 4A, lane 6 and Figure 4B). These results indicate that Sp1 interacts basally, and Egr-1 inducibly, with site -560/-518 in the PDGF-C promoter. Moreover, consistent with EMSA, ChIP analysis revealed that under basal conditions Sp1 is bound to the authentic PDGF-C promoter (Figure 4C), and that both Egr-1 and Sp1 are bound to the promoter upon exposure to ATII (Figure 4C). The identity of the amplicon as a fragment of the PDGF-C promoter was confirmed by nucleotide sequencing (data not shown). Figure 3.Proximal region of the PDGF-C promoter. A consensus Egr-1-binding element was found -543 to -535 bp in the PDGF-C promoter upstream from the G + C-rich element (located -35 to -1 bp) previously found to contain an overlapping Egr-1/Sp1 site (22). The Egr-1 consensus element is denoted by bold type and underline (contained with EMSA probe, PDGF-C(-560/-518) denoted by italics), and the G + C-rich element is defined by bold type and underline. The relative base pairs are represented by numbers in bold type and the curved arrow represents the putative transcriptional start site (as defined by UCSC Genome Database).Figure 4.ATII induces Egr-1 binding to the PDGF-C promoter. (A) EMSA was performed using nuclear extracts from neonatal SMCs treated with or without ATII (10-7 M) for 1 h and 32P-PDGF-C(-560/-518) or 32P-mEgr-1-PDGF-C(-560/-518). Two nucleoprotein complexes (Ni and Nii) formed after incubation of 32P-PDGF-C(-560/-518) with nuclear extracts from cells untreated or treated with ATII. Supershift/band elimination analysis using antibodies to Sp1 and Egr-1 reveal complex Ni contains Sp1 and Egr-1, and complex Nii to contain only Egr-1. Antibodies to ATF4 did not promote shift in any complex. In reactions containing nuclear extracts from untreated or ATII-treated SMCs and 32P-mEgr-1-PDGF-C(-560/-518) (mutant form of the oligonucleotide in which consensus Egr-1 site mutated), neither complex formed. (B) Assessment of band intensities in the 32P-PDGF-C/ATII groups by scanning densitometry. Complex densities for Ni and Nii are indicated. NT denotes non-ATII-treated. (C) ChIP studies show that under basal conditions Sp1 is bound to the authentic PDGF-C promoter, and that both Egr-1 and Sp1 are bound to the promoter upon exposure to ATII. Asterisk (*) denotes P < 0.01 relative to ATII.
###end p 37
###begin p 38
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 347 358 347 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
Proximal region of the PDGF-C promoter. A consensus Egr-1-binding element was found -543 to -535 bp in the PDGF-C promoter upstream from the G + C-rich element (located -35 to -1 bp) previously found to contain an overlapping Egr-1/Sp1 site (22). The Egr-1 consensus element is denoted by bold type and underline (contained with EMSA probe, PDGF-C(-560/-518) denoted by italics), and the G + C-rich element is defined by bold type and underline. The relative base pairs are represented by numbers in bold type and the curved arrow represents the putative transcriptional start site (as defined by UCSC Genome Database).
###end p 38
###begin p 39
###xml 52 53 52 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 148 150 148 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 166 168 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 176 187 176 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 191 193 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 208 219 208 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 289 291 289 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 299 310 299 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 666 668 666 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 683 694 683 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 796 797 796 797 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 837 839 837 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 964 965 964 965 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1158 1159 1158 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
ATII induces Egr-1 binding to the PDGF-C promoter. (A) EMSA was performed using nuclear extracts from neonatal SMCs treated with or without ATII (10-7 M) for 1 h and 32P-PDGF-C(-560/-518) or 32P-mEgr-1-PDGF-C(-560/-518). Two nucleoprotein complexes (Ni and Nii) formed after incubation of 32P-PDGF-C(-560/-518) with nuclear extracts from cells untreated or treated with ATII. Supershift/band elimination analysis using antibodies to Sp1 and Egr-1 reveal complex Ni contains Sp1 and Egr-1, and complex Nii to contain only Egr-1. Antibodies to ATF4 did not promote shift in any complex. In reactions containing nuclear extracts from untreated or ATII-treated SMCs and 32P-mEgr-1-PDGF-C(-560/-518) (mutant form of the oligonucleotide in which consensus Egr-1 site mutated), neither complex formed. (B) Assessment of band intensities in the 32P-PDGF-C/ATII groups by scanning densitometry. Complex densities for Ni and Nii are indicated. NT denotes non-ATII-treated. (C) ChIP studies show that under basal conditions Sp1 is bound to the authentic PDGF-C promoter, and that both Egr-1 and Sp1 are bound to the promoter upon exposure to ATII. Asterisk (*) denotes P < 0.01 relative to ATII.
###end p 39
###begin p 40
###xml 285 287 285 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 295 306 295 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 308 316 308 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 530 532 530 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 540 551 540 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 553 561 553 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 822 824 822 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 832 843 832 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 890 898 890 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 993 1001 993 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1279 1287 1279 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1409 1417 1409 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1451 1460 1451 1460 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1533 1534 1533 1534 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1561 1563 1561 1563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1571 1582 1571 1582 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 1825 1827 1825 1827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1835 1846 1835 1846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 1922 1923 1922 1923 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2042 2043 2034 2035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2152 2153 2136 2137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2448 2449 2422 2423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1460 2458 1460 2432 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="41">Egr-1 and Sp1 cooperatively bind and transactivate the PDGF-C promoter. (<bold>A</bold>) EMSA was performed using <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> and human recombinant Egr-1 (100 ng), human recombinant Sp1 (100 ng) or both human recombinant Egr-1 and Sp1 (100 ng each). A major nucleoprotein complex formed (arrow) only when recombinant Egr-1 and recombinant Sp1 were both incubated with <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup>. The data are representative of three or more independent determinations. (<bold>B</bold>) WKY12-22 SMCs were transfected with 0, 1 and 2 &#181;g of pCB6-Egr-1 (made up to 4 &#181;g total with its backbone pCB6<sup>+</sup>), or identical amounts of pCB6-Egr-1 with 2 &#181;g CMV-Sp1 (made up to 4 &#181;g total with its backbone pCB6<sup>+</sup>), all with pPDGF-C-797 (5 &#181;g) and pRL-null (0.5 &#181;g, to normalize for transfection efficiency). &#8216;Firefly&#8217; luciferase activity was normalized to &#8216;Renilla&#8217;. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.001.</p>
###xml 1460 2458 1460 2432 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="41">Egr-1 and Sp1 cooperatively bind and transactivate the PDGF-C promoter. (<bold>A</bold>) EMSA was performed using <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> and human recombinant Egr-1 (100 ng), human recombinant Sp1 (100 ng) or both human recombinant Egr-1 and Sp1 (100 ng each). A major nucleoprotein complex formed (arrow) only when recombinant Egr-1 and recombinant Sp1 were both incubated with <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup>. The data are representative of three or more independent determinations. (<bold>B</bold>) WKY12-22 SMCs were transfected with 0, 1 and 2 &#181;g of pCB6-Egr-1 (made up to 4 &#181;g total with its backbone pCB6<sup>+</sup>), or identical amounts of pCB6-Egr-1 with 2 &#181;g CMV-Sp1 (made up to 4 &#181;g total with its backbone pCB6<sup>+</sup>), all with pPDGF-C-797 (5 &#181;g) and pRL-null (0.5 &#181;g, to normalize for transfection efficiency). &#8216;Firefly&#8217; luciferase activity was normalized to &#8216;Renilla&#8217;. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.001.</p></caption>
###xml 2458 2458 2432 2432 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm923f5"/>
###xml 1451 2458 1451 2432 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="41">Egr-1 and Sp1 cooperatively bind and transactivate the PDGF-C promoter. (<bold>A</bold>) EMSA was performed using <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup> and human recombinant Egr-1 (100 ng), human recombinant Sp1 (100 ng) or both human recombinant Egr-1 and Sp1 (100 ng each). A major nucleoprotein complex formed (arrow) only when recombinant Egr-1 and recombinant Sp1 were both incubated with <sup>32</sup>P-PDGF-C<sup>(&#8722;560/&#8722;518)</sup>. The data are representative of three or more independent determinations. (<bold>B</bold>) WKY12-22 SMCs were transfected with 0, 1 and 2 &#181;g of pCB6-Egr-1 (made up to 4 &#181;g total with its backbone pCB6<sup>+</sup>), or identical amounts of pCB6-Egr-1 with 2 &#181;g CMV-Sp1 (made up to 4 &#181;g total with its backbone pCB6<sup>+</sup>), all with pPDGF-C-797 (5 &#181;g) and pRL-null (0.5 &#181;g, to normalize for transfection efficiency). &#8216;Firefly&#8217; luciferase activity was normalized to &#8216;Renilla&#8217;. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.001.</p></caption><graphic xlink:href="gkm923f5"/></fig>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 1587 1592 <span type="species:ncbi:9606">human</span>
###xml 1621 1626 <span type="species:ncbi:9606">human</span>
###xml 1660 1665 <span type="species:ncbi:9606">human</span>
###xml 2095 2098 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
In order to confirm the interaction of Sp1 and Egr-1 with this region of the PDGF-C promoter (-560/-518 bp) and to determine whether Sp1 and Egr-1 interact competitively or cooperatively for binding to the overlapping site, EMSA was performed using human recombinant Sp1 and Egr-1 and 32P-PDGF-C(-560/-518) (Figure 5A). In binding reactions containing either recombinant Sp1 or Egr-1, a nucleoprotein complex was not observed. However, a single complex was detected when both Sp1 and Egr-1 were incubated with the oligonucleotide 32P-PDGF-C(-560/-518) (Figure 5A). This data suggests that, individually, Sp1 and Egr-1 are unable to bind this novel element and that presence of the two transcription factors is required for the formation of a single nucleoprotein complex. Interestingly, only one major complex formed when 32P-PDGF-C(-560/-518) was incubated with recombinant Egr-1 and Sp1 (Figure 5A, arrow), which compares with complex Ni (but not Nii) containing both nuclear Sp1 and Egr-1 (Figure 4A and B). To test the hypothesis that Egr-1 and Sp1 co-operatively transactivate the PDGF-C promoter, we performed transient transfection analysis with Egr-1 and Sp1 expression vectors. Transfection with low amounts of Egr-1 results in modest activation of the PDGF-C promoter (Figure 5B, compare columns 2 and 3 to 1), but in the presence of Sp1, the same amounts of Egr-1 produced co-operative activation (Figure 5B, compare columns 5 and 6 to 4). Figure 5.Egr-1 and Sp1 cooperatively bind and transactivate the PDGF-C promoter. (A) EMSA was performed using 32P-PDGF-C(-560/-518) and human recombinant Egr-1 (100 ng), human recombinant Sp1 (100 ng) or both human recombinant Egr-1 and Sp1 (100 ng each). A major nucleoprotein complex formed (arrow) only when recombinant Egr-1 and recombinant Sp1 were both incubated with 32P-PDGF-C(-560/-518). The data are representative of three or more independent determinations. (B) WKY12-22 SMCs were transfected with 0, 1 and 2 microg of pCB6-Egr-1 (made up to 4 microg total with its backbone pCB6+), or identical amounts of pCB6-Egr-1 with 2 microg CMV-Sp1 (made up to 4 microg total with its backbone pCB6+), all with pPDGF-C-797 (5 microg) and pRL-null (0.5 microg, to normalize for transfection efficiency). 'Firefly' luciferase activity was normalized to 'Renilla'. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.001.
###end p 40
###begin p 41
###xml 73 74 73 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 101 103 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 111 122 111 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 365 367 365 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 375 386 375 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 462 463 462 463 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 582 583 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 692 693 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 988 989 962 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 200 205 <span type="species:ncbi:9606">human</span>
###xml 635 638 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Egr-1 and Sp1 cooperatively bind and transactivate the PDGF-C promoter. (A) EMSA was performed using 32P-PDGF-C(-560/-518) and human recombinant Egr-1 (100 ng), human recombinant Sp1 (100 ng) or both human recombinant Egr-1 and Sp1 (100 ng each). A major nucleoprotein complex formed (arrow) only when recombinant Egr-1 and recombinant Sp1 were both incubated with 32P-PDGF-C(-560/-518). The data are representative of three or more independent determinations. (B) WKY12-22 SMCs were transfected with 0, 1 and 2 microg of pCB6-Egr-1 (made up to 4 microg total with its backbone pCB6+), or identical amounts of pCB6-Egr-1 with 2 microg CMV-Sp1 (made up to 4 microg total with its backbone pCB6+), all with pPDGF-C-797 (5 microg) and pRL-null (0.5 microg, to normalize for transfection efficiency). 'Firefly' luciferase activity was normalized to 'Renilla'. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.001.
###end p 41
###begin p 42
###xml 141 143 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 151 162 151 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 328 330 328 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 344 355 344 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;560/&#8722;518)</sup>
###xml 430 432 430 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 445 453 445 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
To determine the nucleotides critical for Egr-1/Sp1 binding to this region of the PDGF-C promoter, a transverse mutation was introduced into 32P-PDGF-C(-560/-518), changing the putative Egr-1 element located -543/-535 bp from 5'-CGCCCCCGC-3' to 5'-ATAAAAATA-3'. EMSA was performed using this mutant form of the oligonucleotide [32P-mEgr1-PDGF-C(-560/-518)] with nuclear extracts from WKY12-22 SMCs treated with or without ATII (10-7 M) for 1 h (Figure 4). Neither Ni nor Nii formed under basal or ATII-stimulated conditions, demonstrating that the integrity of -543/-535 bp is critical for the interaction of Egr-1 and Sp1 with this region of the PDGF-C promoter.
###end p 42
###begin p 43
###xml 333 335 333 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 474 482 474 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 500 508 500 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 672 680 672 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 683 692 683 692 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 1021 1023 1009 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1228 1229 1214 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 692 1237 692 1223 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="44">Novel Egr-1 element in the PDGF-C promoter mediates ATII-inducible PDGF-C expression. Transient transfection analysis was performed on WKY12-22 SMCs transfected with pPDGF-C-797 (5 &#181;g), or pPDGF-C-797.mutEgr-1 (5 &#181;g) and pRL-null (0.5 &#181;g, to normalize for transfection efficiency) and treated with or without ATII (10<sup>&#8722;7</sup> M) for 24 h. &#8216;Firefly&#8217; luciferase activity was normalized to &#8216;Renilla&#8217;. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05.</p>
###xml 692 1237 692 1223 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="44">Novel Egr-1 element in the PDGF-C promoter mediates ATII-inducible PDGF-C expression. Transient transfection analysis was performed on WKY12-22 SMCs transfected with pPDGF-C-797 (5 &#181;g), or pPDGF-C-797.mutEgr-1 (5 &#181;g) and pRL-null (0.5 &#181;g, to normalize for transfection efficiency) and treated with or without ATII (10<sup>&#8722;7</sup> M) for 24 h. &#8216;Firefly&#8217; luciferase activity was normalized to &#8216;Renilla&#8217;. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05.</p></caption>
###xml 1237 1237 1223 1223 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm923f6"/>
###xml 683 1237 683 1223 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="44">Novel Egr-1 element in the PDGF-C promoter mediates ATII-inducible PDGF-C expression. Transient transfection analysis was performed on WKY12-22 SMCs transfected with pPDGF-C-797 (5 &#181;g), or pPDGF-C-797.mutEgr-1 (5 &#181;g) and pRL-null (0.5 &#181;g, to normalize for transfection efficiency) and treated with or without ATII (10<sup>&#8722;7</sup> M) for 24 h. &#8216;Firefly&#8217; luciferase activity was normalized to &#8216;Renilla&#8217;. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkm923f6"/></fig>
To establish the functional significance of this novel element in the PDGF-C promoter, the same transverse mutation was introduced into pPDGF-C-797 (pPDGF-C-797.mutEgr-1) and transient transfection was performed with both wild type and mutant PDGF-C promoter reporter construct. Transfectants were stimulated with or without ATII (10-7 M) for 24 h and PDGF-C promoter activation was analyzed using a luminometer. ATII activated the wild-type PDGF-C promoter by over 7-fold (Figure 6, consistent with Figure 1C), however, no significant difference was observed in PDGF-C promoter activity in cells transfected with pPDGF-C-797.mutEgr-1 treated with ATII or left untreated (Figure 6). Figure 6.Novel Egr-1 element in the PDGF-C promoter mediates ATII-inducible PDGF-C expression. Transient transfection analysis was performed on WKY12-22 SMCs transfected with pPDGF-C-797 (5 microg), or pPDGF-C-797.mutEgr-1 (5 microg) and pRL-null (0.5 microg, to normalize for transfection efficiency) and treated with or without ATII (10-7 M) for 24 h. 'Firefly' luciferase activity was normalized to 'Renilla'. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05.
###end p 43
###begin p 44
###xml 329 331 317 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 536 537 522 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Novel Egr-1 element in the PDGF-C promoter mediates ATII-inducible PDGF-C expression. Transient transfection analysis was performed on WKY12-22 SMCs transfected with pPDGF-C-797 (5 microg), or pPDGF-C-797.mutEgr-1 (5 microg) and pRL-null (0.5 microg, to normalize for transfection efficiency) and treated with or without ATII (10-7 M) for 24 h. 'Firefly' luciferase activity was normalized to 'Renilla'. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05.
###end p 44
###begin p 45
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 555 563 555 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 724 732 724 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 754 762 754 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1096 1104 1096 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1331 1332 1331 1332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1557 1565 1557 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1669 1678 1669 1678 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7.</label>
###xml 1902 1904 1894 1896 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1918 1919 1910 1911 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1946 1947 1938 1939 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2122 2123 2114 2115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2150 2151 2142 2143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2322 2323 2310 2311 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 2391 2392 2375 2376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2538 2540 2514 2516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 2546 2548 2522 2524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 2753 2754 2727 2728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1678 2762 1678 2736 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="46">DNAzymes targeting Egr-1 block ATII-inducible PDGF-C expression. WKY12-22 SMCs were transfected twice with or without the DNAzyme ED5 (0.4 &#181;M) or its scrambled counterpart ED5SCR (0.4 &#181;M) and stimulated with ATII (10<sup>&#8722;7</sup> M) for 2 h. (<bold>A</bold>) Conventional RT-PCR and (<bold>B</bold>) real-time PCR demonstrates the reliance on Egr-1 for ATII-inducible PDGF-C expression. The real-time data represents PDGF-C expression relative to the expression of GAPDH. (<bold>C</bold>) Conventional RT-PCR and (<bold>D</bold>) real-time PCR shows that ED5 (0.4 &#181;M) inhibits ATII-inducible Egr-1 expression. The real-time data represents Egr-1 expression relative to the expression of GAPDH. (<bold>E</bold>) Growth-quiescent WKY12-22 SMCs were transfected with 2 &#181;g pCB6<sup>+</sup> or pCB6-Egr-1, together with pPDGF-C-797 (5 &#181;g) and pRL-null (0.5 &#181;g, to normalize for transfection efficiency), then exposed to ATII (10<sup>&#8722;7</sup> or 10<sup>&#8211;6</sup> M) for 24 h. &#8216;Firefly&#8217; luciferase activity was normalized to &#8216;Renilla&#8217;. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05.</p>
###xml 1678 2762 1678 2736 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="46">DNAzymes targeting Egr-1 block ATII-inducible PDGF-C expression. WKY12-22 SMCs were transfected twice with or without the DNAzyme ED5 (0.4 &#181;M) or its scrambled counterpart ED5SCR (0.4 &#181;M) and stimulated with ATII (10<sup>&#8722;7</sup> M) for 2 h. (<bold>A</bold>) Conventional RT-PCR and (<bold>B</bold>) real-time PCR demonstrates the reliance on Egr-1 for ATII-inducible PDGF-C expression. The real-time data represents PDGF-C expression relative to the expression of GAPDH. (<bold>C</bold>) Conventional RT-PCR and (<bold>D</bold>) real-time PCR shows that ED5 (0.4 &#181;M) inhibits ATII-inducible Egr-1 expression. The real-time data represents Egr-1 expression relative to the expression of GAPDH. (<bold>E</bold>) Growth-quiescent WKY12-22 SMCs were transfected with 2 &#181;g pCB6<sup>+</sup> or pCB6-Egr-1, together with pPDGF-C-797 (5 &#181;g) and pRL-null (0.5 &#181;g, to normalize for transfection efficiency), then exposed to ATII (10<sup>&#8722;7</sup> or 10<sup>&#8211;6</sup> M) for 24 h. &#8216;Firefly&#8217; luciferase activity was normalized to &#8216;Renilla&#8217;. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05.</p></caption>
###xml 2762 2762 2736 2736 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm923f7"/>
###xml 1669 2762 1669 2736 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F7" position="float"><label>Figure 7.</label><caption><p textid="46">DNAzymes targeting Egr-1 block ATII-inducible PDGF-C expression. WKY12-22 SMCs were transfected twice with or without the DNAzyme ED5 (0.4 &#181;M) or its scrambled counterpart ED5SCR (0.4 &#181;M) and stimulated with ATII (10<sup>&#8722;7</sup> M) for 2 h. (<bold>A</bold>) Conventional RT-PCR and (<bold>B</bold>) real-time PCR demonstrates the reliance on Egr-1 for ATII-inducible PDGF-C expression. The real-time data represents PDGF-C expression relative to the expression of GAPDH. (<bold>C</bold>) Conventional RT-PCR and (<bold>D</bold>) real-time PCR shows that ED5 (0.4 &#181;M) inhibits ATII-inducible Egr-1 expression. The real-time data represents Egr-1 expression relative to the expression of GAPDH. (<bold>E</bold>) Growth-quiescent WKY12-22 SMCs were transfected with 2 &#181;g pCB6<sup>+</sup> or pCB6-Egr-1, together with pPDGF-C-797 (5 &#181;g) and pRL-null (0.5 &#181;g, to normalize for transfection efficiency), then exposed to ATII (10<sup>&#8722;7</sup> or 10<sup>&#8211;6</sup> M) for 24 h. &#8216;Firefly&#8217; luciferase activity was normalized to &#8216;Renilla&#8217;. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkm923f7"/></fig>
###xml 591 594 <span type="species:ncbi:10116">rat</span>
###xml 645 648 <span type="species:ncbi:9823">pig</span>
The preceding data demonstrate that Egr-1 inducibly binds to a novel upstream element in the PDGF-C promoter. To directly establish that Egr-1 mediates ATII-inducible PDGF-C expression, we assessed PDGF-C mRNA levels in neonatal SMCs that had been transfected with the Egr-1 DNAzyme, ED5 (25) or its arm-scrambled counterpart, ED5SCR, and stimulated with ATII for 2 h. DNAzymes are sequence-specific 'gene knockdown' agents that bind to and cleave the mRNA of their target gene (28,29). We have previously used DNAzymes to inhibit gene expression in SMCs in vitro and neointima formation in rat carotid arteries after balloon injury (25) and in pig coronary arteries following stenting (30). Using both conventional RT-PCR (Figure 7A) and real-time PCR (Figure 7B), our findings demonstrate that ED5, but not ED5SCR, perturbed the stimulatory effect of ATII on PDGF-C mRNA expression. To support these observations, we evaluated the effect of ED5 on levels of Egr-1 either by conventional or quantitative real-time PCR. ED5 inhibited the induction of Egr-1 by ATII, whereas ED5SCR had no effect (Figure 7C and D). These findings together demonstrate the dependence of ATII induction of PDGF-C expression on Egr-1. To demonstrate whether exogenous Egr-1 enhances the induction of PDGF-C by ATII, we co-transfected pCB6-Egr-1 or pCB6+ with pPDGF-C-797 and luciferase activity was assessed with or without exposure of the cells to ATII. We observed that a fixed amount of Egr-1 potentiated ATII-inducible PDGF-C transcription in an ATII dose-dependent manner (Figure 7E). Taken together, these data demonstrate that Egr-1 is critical for ATII-inducible PDGF-C expression. Figure 7.DNAzymes targeting Egr-1 block ATII-inducible PDGF-C expression. WKY12-22 SMCs were transfected twice with or without the DNAzyme ED5 (0.4 microM) or its scrambled counterpart ED5SCR (0.4 microM) and stimulated with ATII (10-7 M) for 2 h. (A) Conventional RT-PCR and (B) real-time PCR demonstrates the reliance on Egr-1 for ATII-inducible PDGF-C expression. The real-time data represents PDGF-C expression relative to the expression of GAPDH. (C) Conventional RT-PCR and (D) real-time PCR shows that ED5 (0.4 microM) inhibits ATII-inducible Egr-1 expression. The real-time data represents Egr-1 expression relative to the expression of GAPDH. (E) Growth-quiescent WKY12-22 SMCs were transfected with 2 microg pCB6+ or pCB6-Egr-1, together with pPDGF-C-797 (5 microg) and pRL-null (0.5 microg, to normalize for transfection efficiency), then exposed to ATII (10-7 or 10-6 M) for 24 h. 'Firefly' luciferase activity was normalized to 'Renilla'. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05.
###end p 45
###begin p 46
###xml 224 226 216 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 240 241 232 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 268 269 260 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 444 445 436 437 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 472 473 464 465 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 644 645 632 633 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 713 714 697 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 860 862 836 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 868 870 844 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 1075 1076 1049 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
DNAzymes targeting Egr-1 block ATII-inducible PDGF-C expression. WKY12-22 SMCs were transfected twice with or without the DNAzyme ED5 (0.4 microM) or its scrambled counterpart ED5SCR (0.4 microM) and stimulated with ATII (10-7 M) for 2 h. (A) Conventional RT-PCR and (B) real-time PCR demonstrates the reliance on Egr-1 for ATII-inducible PDGF-C expression. The real-time data represents PDGF-C expression relative to the expression of GAPDH. (C) Conventional RT-PCR and (D) real-time PCR shows that ED5 (0.4 microM) inhibits ATII-inducible Egr-1 expression. The real-time data represents Egr-1 expression relative to the expression of GAPDH. (E) Growth-quiescent WKY12-22 SMCs were transfected with 2 microg pCB6+ or pCB6-Egr-1, together with pPDGF-C-797 (5 microg) and pRL-null (0.5 microg, to normalize for transfection efficiency), then exposed to ATII (10-7 or 10-6 M) for 24 h. 'Firefly' luciferase activity was normalized to 'Renilla'. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05.
###end p 46
###begin p 47
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 549 557 545 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 560 569 556 565 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8.</label>
###xml 787 789 778 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1168 1169 1157 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 569 1177 565 1166 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">ATII-inducible PDGF-C expression acts through the AT1 receptor. WKY12-22 SMCs cells were treated with the AT1R inhibitor Losartan (1&#956;M) or AT2R inhibitor, PD123319 (1 &#181;M) for 1 h prior to stimulation with ATII (10<sup>&#8722;7</sup> M) for 2 h. mRNA was isolated and real-time PCR was performed simultaneously for PDGF-C and GAPDH, a housekeeping gene. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05.</p>
###xml 569 1177 565 1166 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="48">ATII-inducible PDGF-C expression acts through the AT1 receptor. WKY12-22 SMCs cells were treated with the AT1R inhibitor Losartan (1&#956;M) or AT2R inhibitor, PD123319 (1 &#181;M) for 1 h prior to stimulation with ATII (10<sup>&#8722;7</sup> M) for 2 h. mRNA was isolated and real-time PCR was performed simultaneously for PDGF-C and GAPDH, a housekeeping gene. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05.</p></caption>
###xml 1177 1177 1166 1166 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm923f8"/>
###xml 560 1177 556 1166 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F8" position="float"><label>Figure 8.</label><caption><p textid="48">ATII-inducible PDGF-C expression acts through the AT1 receptor. WKY12-22 SMCs cells were treated with the AT1R inhibitor Losartan (1&#956;M) or AT2R inhibitor, PD123319 (1 &#181;M) for 1 h prior to stimulation with ATII (10<sup>&#8722;7</sup> M) for 2 h. mRNA was isolated and real-time PCR was performed simultaneously for PDGF-C and GAPDH, a housekeeping gene. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkm923f8"/></fig>
We next investigated the ATII receptor subtype mediating ATII-inducible PDGF-C expression using pharmacologic inhibitors. mRNA was isolated from WKY12-22 SMCs treated with Losartan (14), a competitive inhibitor of AT1R, or the AT2R antagonist PD123319 (14) for 1 h (both at 1 microM) prior to stimulation with ATII for 2 h. mRNA was reverse-transcribed to cDNA and real-time PCR was performed for PDGF-C. Losartan blocked ATII-inducible PDGF-C expression demonstrating that ATII employs the AT1 receptor to effect changes in PDGF-C gene expression (Figure 8). Figure 8.ATII-inducible PDGF-C expression acts through the AT1 receptor. WKY12-22 SMCs cells were treated with the AT1R inhibitor Losartan (1muM) or AT2R inhibitor, PD123319 (1 microM) for 1 h prior to stimulation with ATII (10-7 M) for 2 h. mRNA was isolated and real-time PCR was performed simultaneously for PDGF-C and GAPDH, a housekeeping gene. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05.
###end p 47
###begin p 48
###xml 218 220 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 599 600 592 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
ATII-inducible PDGF-C expression acts through the AT1 receptor. WKY12-22 SMCs cells were treated with the AT1R inhibitor Losartan (1muM) or AT2R inhibitor, PD123319 (1 microM) for 1 h prior to stimulation with ATII (10-7 M) for 2 h. mRNA was isolated and real-time PCR was performed simultaneously for PDGF-C and GAPDH, a housekeeping gene. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05.
###end p 48
###begin p 49
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 531 533 531 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 583 591 583 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Figure 9</xref>
###xml 654 663 654 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 675 676 675 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 688 689 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8</xref>
###xml 753 761 753 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Figure 9</xref>
###xml 1055 1063 1055 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Figure 9</xref>
###xml 1123 1131 1123 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1647 1656 1647 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F10">Figure 10</xref>
###xml 1769 1778 1769 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F10">Figure 10</xref>
###xml 1863 1872 1863 1872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F10">Figure 10</xref>
###xml 1971 1980 1971 1980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F10">Figure 10</xref>
###xml 2124 2132 2124 2132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 2257 2259 2257 2259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 2754 2759 2754 2759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14 B15 B16">14&#8211;16</xref>
###xml 3616 3625 3616 3625 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 9.</label>
###xml 3760 3762 3760 3762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 3789 3790 3789 3790 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 3811 3812 3811 3812 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 4158 4159 4158 4159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 4185 4186 4185 4186 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 4554 4555 4552 4553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 3625 4562 3625 4560 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="50">ATII does not induce PDGF-C expression in rat adult SMCs. mRNA was isolated from adult rat aortic SMCs treated with or without ATII (10<sup>&#8722;7</sup> M) for 0.5, 2, 4 or 8 h. (<bold>A</bold>) Real-time PCR and (<bold>B</bold>) conventional RT-PCR were performed simultaneously for PDGF-C and GAPDH, a housekeeping gene, as described in the Materials and Methods section. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. (<bold>C</bold>) Conventional RT-PCR or (<bold>D</bold>) real-time PCR was performed simultaneously for Egr-1 as described in the Materials and Methods section. The graph represents Egr-1 expression relative to the expression of beta-actin to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05</p>
###xml 3625 4562 3625 4560 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="50">ATII does not induce PDGF-C expression in rat adult SMCs. mRNA was isolated from adult rat aortic SMCs treated with or without ATII (10<sup>&#8722;7</sup> M) for 0.5, 2, 4 or 8 h. (<bold>A</bold>) Real-time PCR and (<bold>B</bold>) conventional RT-PCR were performed simultaneously for PDGF-C and GAPDH, a housekeeping gene, as described in the Materials and Methods section. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. (<bold>C</bold>) Conventional RT-PCR or (<bold>D</bold>) real-time PCR was performed simultaneously for Egr-1 as described in the Materials and Methods section. The graph represents Egr-1 expression relative to the expression of beta-actin to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05</p></caption>
###xml 4562 4562 4560 4560 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm923f9"/>
###xml 3616 4562 3616 4560 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F9" position="float"><label>Figure 9.</label><caption><p textid="50">ATII does not induce PDGF-C expression in rat adult SMCs. mRNA was isolated from adult rat aortic SMCs treated with or without ATII (10<sup>&#8722;7</sup> M) for 0.5, 2, 4 or 8 h. (<bold>A</bold>) Real-time PCR and (<bold>B</bold>) conventional RT-PCR were performed simultaneously for PDGF-C and GAPDH, a housekeeping gene, as described in the Materials and Methods section. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. (<bold>C</bold>) Conventional RT-PCR or (<bold>D</bold>) real-time PCR was performed simultaneously for Egr-1 as described in the Materials and Methods section. The graph represents Egr-1 expression relative to the expression of beta-actin to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05</p></caption><graphic xlink:href="gkm923f9"/></fig>
###xml 4562 4572 4560 4570 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 10.</label>
###xml 4688 4689 4686 4687 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 5048 5049 5020 5021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 5059 5060 5031 5032 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 4572 5196 4570 5168 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="51">Mutation of the upstream element abrogates Egr-1, but not Sp1, activation of the PDGF-C promoter in neonatal SMCs. (<bold>A</bold>) Transient co-transfection analysis was performed in WKY12-22 SMCs with pPDGF-C-797 (5 &#181;g) or pPDGF-C-797.mutEgr-1 (5 &#181;g) and pCB6-Egr-1 (2 &#181;g), pCB6-Egr-1 (2 &#181;g), CMV-gutless (2 &#181;g) or CMV-Sp1 (2 &#181;g). The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05. (<bold>B</bold>) Western blot analysis demonstrates that Egr-1 and Sp1 levels are increased in SMCs transfected with the respective expression vectors.</p>
###xml 4572 5196 4570 5168 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="51">Mutation of the upstream element abrogates Egr-1, but not Sp1, activation of the PDGF-C promoter in neonatal SMCs. (<bold>A</bold>) Transient co-transfection analysis was performed in WKY12-22 SMCs with pPDGF-C-797 (5 &#181;g) or pPDGF-C-797.mutEgr-1 (5 &#181;g) and pCB6-Egr-1 (2 &#181;g), pCB6-Egr-1 (2 &#181;g), CMV-gutless (2 &#181;g) or CMV-Sp1 (2 &#181;g). The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05. (<bold>B</bold>) Western blot analysis demonstrates that Egr-1 and Sp1 levels are increased in SMCs transfected with the respective expression vectors.</p></caption>
###xml 5196 5196 5168 5168 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm923f10"/>
###xml 4562 5196 4560 5168 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F10" position="float"><label>Figure 10.</label><caption><p textid="51">Mutation of the upstream element abrogates Egr-1, but not Sp1, activation of the PDGF-C promoter in neonatal SMCs. (<bold>A</bold>) Transient co-transfection analysis was performed in WKY12-22 SMCs with pPDGF-C-797 (5 &#181;g) or pPDGF-C-797.mutEgr-1 (5 &#181;g) and pCB6-Egr-1 (2 &#181;g), pCB6-Egr-1 (2 &#181;g), CMV-gutless (2 &#181;g) or CMV-Sp1 (2 &#181;g). The data are representative of three or more independent determinations. Error bars represent the mean &#177; SE. Asterisk (*) denotes <italic>P</italic> &lt; 0.05. (<bold>B</bold>) Western blot analysis demonstrates that Egr-1 and Sp1 levels are increased in SMCs transfected with the respective expression vectors.</p></caption><graphic xlink:href="gkm923f10"/></fig>
###xml 360 363 <span type="species:ncbi:10116">rat</span>
###xml 496 499 <span type="species:ncbi:10116">rat</span>
###xml 3667 3670 <span type="species:ncbi:10116">rat</span>
###xml 3712 3715 <span type="species:ncbi:10116">rat</span>
###xml 4870 4873 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 4896 4899 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
SMCs are well known for their phenotypically heterogeneity, particularly during development and arterial remodeling in atherosclerosis and restenosis in adults. Previous studies examining ATII-inducible PDGF-B expression revealed SMC subtype-specific responsiveness (15). ATII regulation of PDGF-A (14) or PDGF-D (16) expression has only been studied in adult rat SMCs. To determine whether ATII regulation of PDGF-C expression is SMC differentiation state-dependent, we isolated mRNA from adult rat aortic SMCs exposed to ATII (10-7 M) for various times and assessed PDGF-C levels (Figure 9A and B). In contrast to results obtained using neonatal SMCs (Figures 1A-C, 5B, 6, 7A, B, E and 8), ATII did not influence PDGF-C mRNA expression in adult SMCs (Figure 9A and B), indicating that PDGF-C expression in SMC is differentiation state-specific. We explored whether the inability of ATII to influence PDGF-C expression in adult SMCs is due to the lack of induction of Egr-1 by ATII in this cell type. ATII stimulated Egr-1 mRNA expression in adult SMCs (Figure 9C and D) as it did together with protein in neonatal cells (Figure 2B and C). These observations therefore indicate Egr-1-dependent and -independent transcriptional control of PDGF-C between these SMC subtypes. To determine the functional importance of this upstream element in relation to Egr-1 and Sp1, transient co-transfection analysis was performed in WKY12-22 SMCs using wild-type (pPDGF-C-797) and mutant (pPDGF-C-797.mutEgr1) PDGF-C promoter together with expression vectors for Egr-1 and Sp1. Both transcription factors, as expected, activated the wild-type PDGF-C promoter (Figure 10A). However, whereas mutation of the distal element (-543/-535) blocked Egr-1 activation of the PDGF-C promoter (Figure 10A), disruption of this element did not alter Sp1's ability to activate the promoter (Figure 10A). That Egr-1 and Sp1 were overexpressed in this context was demonstrated by immunoblot analysis (Figure 10B). These findings demonstrate that Sp1's transactivation of the PDGF-C promoter is not mediated by -543/-535, although Sp1 binds this element (Figure 4A-C). SMCs of distinct differentiation state respond to changes in the extracellular environment through different pathways (31). The present study demonstrates that ATII-inducible PDGF-C expression in SMCs is dissimilarly regulated in cells of neonatal and adult origin, by providing evidence for a novel ATII-AT1R-Egr-1-PDGF-C axis in SMCs of neonatal origin, but not in adult SMCs, where ATII induces Egr-1 but not PDGF-C. This study also demonstrates that ATII is a positive regulator of PDGF-C gene expression in neonatal SMCs, and for the first time, defines ATII as an agonist of all four known PDGF ligand chains (14-16). Using nuclear extracts and recombinant proteins, we discovered this novel upstream element cooperatively binds both Egr-1 and Sp1, and mediates ATII-inducible PDGF-C expression. DNAzymes targeting Egr-1 mRNA established that Egr-1 plays a critical role in ATII-inducible PDGF-C expression. Additionally, by using pharmacologic inhibitors of each ATII receptor, AT1R and AT2R, we demonstrated that ATII acts through AT1R to induce PDGF-C expression. Element -543/-535 plays a critical role in both Egr-1- and ATII-activation of the PDGF-C promoter. Thus, although Egr-1 is a key regulator of ATII-inducible PDGF-C expression, this present study invites further investigation to rationalize differences in the transcriptional regulation of PDGF-C between SMC subtypes. This information will help develop a more detailed understanding of SMC heterogeneity. Figure 9.ATII does not induce PDGF-C expression in rat adult SMCs. mRNA was isolated from adult rat aortic SMCs treated with or without ATII (10-7 M) for 0.5, 2, 4 or 8 h. (A) Real-time PCR and (B) conventional RT-PCR were performed simultaneously for PDGF-C and GAPDH, a housekeeping gene, as described in the Materials and Methods section. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. (C) Conventional RT-PCR or (D) real-time PCR was performed simultaneously for Egr-1 as described in the Materials and Methods section. The graph represents Egr-1 expression relative to the expression of beta-actin to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05Figure 10.Mutation of the upstream element abrogates Egr-1, but not Sp1, activation of the PDGF-C promoter in neonatal SMCs. (A) Transient co-transfection analysis was performed in WKY12-22 SMCs with pPDGF-C-797 (5 microg) or pPDGF-C-797.mutEgr-1 (5 microg) and pCB6-Egr-1 (2 microg), pCB6-Egr-1 (2 microg), CMV-gutless (2 microg) or CMV-Sp1 (2 microg). The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05. (B) Western blot analysis demonstrates that Egr-1 and Sp1 levels are increased in SMCs transfected with the respective expression vectors.
###end p 49
###begin p 50
###xml 135 137 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 164 165 164 165 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 186 187 186 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 533 534 533 534 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 560 561 560 561 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 929 930 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 42 45 <span type="species:ncbi:10116">rat</span>
###xml 87 90 <span type="species:ncbi:10116">rat</span>
ATII does not induce PDGF-C expression in rat adult SMCs. mRNA was isolated from adult rat aortic SMCs treated with or without ATII (10-7 M) for 0.5, 2, 4 or 8 h. (A) Real-time PCR and (B) conventional RT-PCR were performed simultaneously for PDGF-C and GAPDH, a housekeeping gene, as described in the Materials and Methods section. The graph represents PDGF-C expression relative to the expression of GAPDH to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. (C) Conventional RT-PCR or (D) real-time PCR was performed simultaneously for Egr-1 as described in the Materials and Methods section. The graph represents Egr-1 expression relative to the expression of beta-actin to correct for cDNA concentration between samples. The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05
###end p 50
###begin p 51
###xml 116 117 116 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 476 477 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 487 488 461 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 298 301 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 324 327 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Mutation of the upstream element abrogates Egr-1, but not Sp1, activation of the PDGF-C promoter in neonatal SMCs. (A) Transient co-transfection analysis was performed in WKY12-22 SMCs with pPDGF-C-797 (5 microg) or pPDGF-C-797.mutEgr-1 (5 microg) and pCB6-Egr-1 (2 microg), pCB6-Egr-1 (2 microg), CMV-gutless (2 microg) or CMV-Sp1 (2 microg). The data are representative of three or more independent determinations. Error bars represent the mean +/- SE. Asterisk (*) denotes P < 0.05. (B) Western blot analysis demonstrates that Egr-1 and Sp1 levels are increased in SMCs transfected with the respective expression vectors.
###end p 51
###begin title 52
ACKNOWLEDGEMENTS
###end title 52
###begin p 53
The authors are indebted to Fernando Santiago for technical assistance and other members of the Gene Targeting and Transcription Laboratory at UNSW. Funding to pay the Open Access publication charges for this article was provided by the Centre for Vascular Research. This work was supported by grants from the NHMRC, ARC and NHF.
###end p 53
###begin p 54
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 54
###begin title 55
REFERENCES
###end title 55
###begin article-title 56
PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor
###end article-title 56
###begin article-title 57
The pathogenesis of atherosclerosis: a perspective for the 1990s
###end article-title 57
###begin article-title 58
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
###end article-title 58
###begin article-title 59
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy
###end article-title 59
###begin article-title 60
Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors
###end article-title 60
###begin article-title 61
Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors
###end article-title 61
###begin article-title 62
###xml 53 58 <span type="species:ncbi:9606">human</span>
PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases
###end article-title 62
###begin article-title 63
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Expression analysis of PDGF-C in adult and developing mouse tissues
###end article-title 63
###begin article-title 64
###xml 67 70 <span type="species:ncbi:10116">rat</span>
The expression of SCDGF/PDGF-C/fallotein and SCDGF-B/PDGF-D in the rat central nervous system
###end article-title 64
###begin article-title 65
A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling
###end article-title 65
###begin article-title 66
PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle
###end article-title 66
###begin article-title 67
Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases
###end article-title 67
###begin article-title 68
Angiotensin II (ATII)-inducible platelet-derived growth factor A-chain gene expression is p42/44 extracellular signal-regulated kinase-1/2 and Egr-1 dependent and modulated via the ATII type 1 but not type 2 receptor - induction by ATII antagonized by nitric oxide
###end article-title 68
###begin article-title 69
###xml 87 90 <span type="species:ncbi:10116">rat</span>
Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms
###end article-title 69
###begin article-title 70
Inducible platelet-derived growth factor D-chain expression by angiotensin II and hydrogen peroxide involves transcriptional regulation by Ets-1 and Sp1
###end article-title 70
###begin article-title 71
Angiotensin II signaling in vascular smooth muscle. New concepts
###end article-title 71
###begin article-title 72
Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development
###end article-title 72
###begin article-title 73
###xml 65 69 <span type="species:ncbi:10116">rats</span>
Characterization of cloned aortic smooth muscle cells from young rats
###end article-title 73
###begin article-title 74
###xml 132 136 <span type="species:ncbi:10116">rats</span>
Zinc finger transcription factors mediate high constitutive PDGF-B expression in smooth muscle cells derived from aortae of newborn rats
###end article-title 74
###begin article-title 75
Interplay of Sp1 and Egr-1 in the proximal PDGF-A promoter in cultured vascular endothelial cells
###end article-title 75
###begin article-title 76
Fibroblast growth factor-2 induction of platelet-derived growth factor-C chain transcription in vascular smooth muscle cells is ERK-dependent but not JNK-dependent and mediated by Egr-1
###end article-title 76
###begin article-title 77
FGF-1-induced PDGF A-chain gene expression in vascular endothelial cells involves transcriptional activation by Egr-1
###end article-title 77
###begin article-title 78
Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress response element in the PDGF A-chain promoter
###end article-title 78
###begin article-title 79
New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth factor injury
###end article-title 79
###begin article-title 80
Fast chromatin immunoprecipitation assay
###end article-title 80
###begin article-title 81
###xml 53 58 <span type="species:ncbi:9606">human</span>
The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites
###end article-title 81
###begin article-title 82
Catalytic DNA as therapeutic agents and molecular tools to dissect biological function
###end article-title 82
###begin article-title 83
Nucleic acid based strategies as potential therpeautic tools: mechanistic considerations and implications to restenosis
###end article-title 83
###begin article-title 84
Catalytic oligodeoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis
###end article-title 84
###begin article-title 85
Molecular regulation of vascular smooth muscle cell differentiation in development and disease
###end article-title 85

